Congress extends diabetes research funding through 2030
H.R. 5461 — Special Diabetes Program Reauthorization Act of 2025 · Filed by Diana DeGette (D-CO) · 49 cosponsors · Introduced Sep 18, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill extends federal funding for the Special Diabetes Program for Type I diabetes by appropriating $160 million per year for fiscal years 2026–2030. The program provides grants to health centers and researchers to improve diabetes care and prevention. The bill simply adds a new funding line to an existing program authorization.
Why we flagged it
The bill is a straightforward extension of existing federal funding for a diabetes research and care program. It adds appropriations to an established public health initiative with no structural changes or private carve-outs.
Who it affects
The bill extends dedicated federal funding for a public health program that directly supports Type I diabetes research, care coordination, and prevention services. Citizens with Type I diabetes and underserved communities benefit from sustained program resources.